Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Long

Showing results (31-40 of 466) with videos related to

Pageof 47
Sort By:
Cancer Immunology Research|April 26, 2019
CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7<sup>+</sup> Tumor CellsXiaoxuan Zhuang, Eric O Long
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cellsS Rajagopalan, E O Long
The Journal of Experimental Medicine|January 8, 2003
Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid raftsCarsten Watzl, Eric O Long
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2022
CRISPR Screen to Identify Factors that Render Tumor Cells Sensitive or Resistant to Killing by NK CellsXiaoxuan Zhuang, Eric O Long
The Journal of Experimental Medicine|April 6, 1999
A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cellsS Rajagopalan, E O Long
Home Healthcare Nurse|January 25, 2003
What's new in Alzheimer's disease?Carol O Long, Jan Dougherty
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potentialMathias Faure, Eric O Long
Frontiers in Immunology|August 31, 2012
KIR2DL4 (CD158d): An activation receptor for HLA-GSumati Rajagopalan, Eric O Long
Trends in Immunology|June 28, 2005
Viral evasion of NK-cell activationSumati Rajagopalan, Eric O Long
Home Healthcare Nurse|January 6, 2006
Emergency preparedness for the home healthcare nurseDarlene Rodriguez, Carol O Long
Pageof 47

Showing results (31-40 of 466) with videos related to

Sort By:
Pageof 47
Cancer Immunology Research|April 26, 2019
CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7<sup>+</sup> Tumor CellsXiaoxuan Zhuang, Eric O Long
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cellsS Rajagopalan, E O Long
The Journal of Experimental Medicine|January 8, 2003
Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid raftsCarsten Watzl, Eric O Long
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2022
CRISPR Screen to Identify Factors that Render Tumor Cells Sensitive or Resistant to Killing by NK CellsXiaoxuan Zhuang, Eric O Long
The Journal of Experimental Medicine|April 6, 1999
A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cellsS Rajagopalan, E O Long
Home Healthcare Nurse|January 25, 2003
What's new in Alzheimer's disease?Carol O Long, Jan Dougherty
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potentialMathias Faure, Eric O Long
Frontiers in Immunology|August 31, 2012
KIR2DL4 (CD158d): An activation receptor for HLA-GSumati Rajagopalan, Eric O Long
Trends in Immunology|June 28, 2005
Viral evasion of NK-cell activationSumati Rajagopalan, Eric O Long
Home Healthcare Nurse|January 6, 2006
Emergency preparedness for the home healthcare nurseDarlene Rodriguez, Carol O Long
Pageof 47